Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacologic Relapse Prevention for Alcoholic Smokers
NCT00000457Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Jun 1998
- Primary completion
- Apr 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bupropion in Tobacco Use Disorder (TUD), sponsored by Mayo Clinic. Started Jun 1998; status: completed.
02
Drugs
bupropion
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT00000457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000457.